| Announce Date | 09/04/2025 |
| EPS Normalized Actual | $1.26 (Beat by $0.09) |
| EPS GAAP Actual | $1.26 (Beat by $0.09) |
| Revenue Actual | $0.397275B |
| Revenue Surprise | Beat by $397.275M |
| Announce Date | 10/30/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.24 |
| EPS GAAP Estimate | $1.24 |
| Revenue Estimate | $0.3623B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jul 2026 | 5.02 | 15.01 | 4.9762 | 5.06582 | 0 |
| Jul 2025 | 4.15 | 18.16 | 4.15 | 4.15 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 1.05 | -0.145 | 0.397275B | 13.56% | 28.1M |
| FQ2 2025 (Apr 2025) | 1.1 | -0.06 | 0.38259B | 10.25% | 23.89M |
| FQ1 2025 (Jan 2025) | 0.84 | 0.84 | 0.356675B | 9.55% | 356.68M |
| FQ4 2024 (Oct 2024) | 0.98 | 0.98 | 0.377065B | 11.96% | 377.07M |
| FQ3 2024 (Jul 2024) | 1.17 | 1.17 | 0.343402B | -0.74% | 343.4M |
| FQ2 2024 (Apr 2024) | 1.06 | 1.06 | 0.343384B | 100% | 343.38M |
| FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 0.322624B | -1.12% | 322.62M |
| FQ4 2023 (Oct 2023) | 0.97 | 0.97 | 0.331983B | 100% | 331.98M |
FQ4 Announce Date
10/30/2025 (Pre-Market)
Consensus EPS Estimates
1.24
Consensus Revenue Estimates
0.3623B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 1.465 | -- | 1.46483 | 1.46517 | 1 |
| FQ2 2027 (Apr 2027) | 1.415 | -- | 1.41483 | 1.41517 | 1 |
| FQ1 2027 (Jan 2027) | 1.185 | -- | 1.18486 | 1.18514 | 1 |
| FQ4 2026 (Oct 2026) | 1.275 | -- | 1.27485 | 1.27515 | 1 |
| FQ3 2026 (Jul 2026) | 1.35 | 22.22 | 1.34007 | 1.36852 | 0 |
| FQ2 2026 (Apr 2026) | 1.33 | 17.29 | 1.32022 | 1.34824 | 0 |
| FQ1 2026 (Jan 2026) | 1.1 | 23.64 | 1.08938 | 1.11041 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2027 (Jul 2027) | 0.42B | -- | 0.42B | 0.42B | 1 |
| FQ2 2027 (Apr 2027) | 0.42B | -- | 0.42B | 0.42B | 1 |
| FQ1 2027 (Jan 2027) | 0.39B | -- | 0.39B | 0.39B | 1 |
| FQ4 2026 (Oct 2026) | 0.41B | -- | 0.41B | 0.41B | 1 |
| FQ3 2026 (Jul 2026) | 0.39B | -2.52 | 0.39B | 0.39B | 2 |
| FQ2 2026 (Apr 2026) | 0.38B | -1.43 | 0.38B | 0.38B | 2 |
| FQ1 2026 (Jan 2026) | 0.35B | -0.93 | 0.35B | 0.36B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | 1.195 | 1.05 | -0.145 | -13.81% |
| FQ2 2025 (Apr 2025) | 1.16 | 1.1 | -0.06 | -5.45% |
| FQ1 2025 (Jan 2025) | 0.84 | 0.84 | 100% | |
| FQ4 2024 (Oct 2024) | 0.98 | 0.98 | 100% | |
| FQ3 2024 (Jul 2024) | 1.17 | 1.17 | 100% | |
| FQ2 2024 (Apr 2024) | 1.06 | 1.06 | 100% | |
| FQ1 2024 (Jan 2024) | 0.9 | 0.9 | 100% | |
| FQ4 2023 (Oct 2023) | 0.97 | 0.97 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Jul 2025) | $0.37B | $0.4B | $28.1M | 7.07% |
| FQ2 2025 (Apr 2025) | $0.36B | $0.38B | $23.89M | 6.24% |
| FQ1 2025 (Jan 2025) | $0B | $0.36B | $356.68M | 100% |
| FQ4 2024 (Oct 2024) | $0B | $0.38B | $377.07M | 100% |
| FQ3 2024 (Jul 2024) | $0B | $0.34B | $343.4M | 100% |
| FQ2 2024 (Apr 2024) | $0B | $0.34B | $343.38M | 100% |
| FQ1 2024 (Jan 2024) | $0B | $0.32B | $322.62M | 100% |
| FQ4 2023 (Oct 2023) | $0B | $0.33B | $331.98M | 100% |